Page last updated: 2024-08-22

mannose and Leishmaniasis

mannose has been researched along with Leishmaniasis in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's1 (10.00)18.2507
2000's3 (30.00)29.6817
2010's4 (40.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Chowdhuri, S; Das, BK; Das, D; Das, S; Dowari, P; Kushwaha, R; Roy, S; Ukil, A1
Akhtar, S; Ashraf, S; Hussain, I; Hussain, SZ; Rafay, M; Sarwar, HS; Shahnaz, G; Sohail, MF; Yasinzai, M1
Azevedo, RB; Biswaro, LS; da Silva, JR; Escobar, P; Garcia, MP; Neira Fuentes, LF; Vera, A1
Barros, D; Cordeiro-da-Silva, A; Costa Lima, SA1
Ali, N; Veerareddy, PR; Vobalaboina, V1
Mishra, PR; Singodia, D; Verma, A; Verma, RK1
Asanuma, H; Gomi, T; Kojima, N; Nakata, M; Shimizu, Y; Tadakuma, T; Yamakami, K1
Basu, MK; Giri, VS; Jaisankar, P; Manna, RK; Medda, S; Pal, B1
Bernd, P; Rabinovitch, M; Shepherd, VL; Stahl, PD1
Barbieri, CL; Cantos, G; Gorin, PA; Iacomini, M; Travassos, LR1

Other Studies

10 other study(ies) available for mannose and Leishmaniasis

ArticleYear
Mannose-Decorated Composite Peptide Hydrogel with Thixotropic and Syneresis Properties and its Application in Treatment of Leishmaniasis.
    Chemistry, an Asian journal, 2022, Sep-14, Volume: 17, Issue:18

    Topics: Humans; Hydrogels; Leishmaniasis; Leishmaniasis, Visceral; Mannose; Peptides

2022
Mannosylated thiolated polyethylenimine nanoparticles for the enhanced efficacy of antimonial drug against Leishmaniasis.
    Nanomedicine (London, England), 2018, Volume: 13, Issue:1

    Topics: Antiprotozoal Agents; Biological Transport; Chitosan; Drug Carriers; Drug Liberation; Humans; Leishmania; Leishmaniasis; Mannose; Meglumine; Meglumine Antimoniate; Nanoparticles; Organometallic Compounds; Particle Size; Polyethyleneimine; Sulfhydryl Compounds; Surface Properties

2018
Itraconazole encapsulated PLGA-nanoparticles covered with mannose as potential candidates against leishmaniasis.
    Journal of biomedical materials research. Part B, Applied biomaterials, 2019, Volume: 107, Issue:3

    Topics: Animals; Antiprotozoal Agents; Coated Materials, Biocompatible; Humans; Itraconazole; Leishmania; Leishmaniasis; Mannose; Mice; Nanocapsules; Polylactic Acid-Polyglycolic Acid Copolymer; THP-1 Cells

2019
Surface functionalization of polymeric nanospheres modulates macrophage activation: relevance in leishmaniasis therapy.
    Nanomedicine (London, England), 2015, Volume: 10, Issue:3

    Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cells, Cultured; Cytokines; Drug Carriers; Lactic Acid; Leishmaniasis; Macrophage Activation; Macrophages; Male; Mannans; Mannose; Mice; Mice, Inbred BALB C; Nanospheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers

2015
Antileishmanial activity, pharmacokinetics and tissue distribution studies of mannose-grafted amphotericin B lipid nanospheres.
    Journal of drug targeting, 2009, Volume: 17, Issue:2

    Topics: Amphotericin B; Animals; Brain; Drug Carriers; Kidney; Leishmania donovani; Leishmaniasis; Liver; Mannose; Mice; Mice, Inbred BALB C; Nanospheres; Spleen; Tissue Distribution; Trypanocidal Agents

2009
Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulfated N-acetyl galactosamine more efficiently in comparison with mannose-decorated liposomes: an application in drug delivery.
    Nanomedicine : nanotechnology, biology, and medicine, 2012, Volume: 8, Issue:4

    Topics: Acetylglucosamine; Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Drug Evaluation, Preclinical; Humans; Lectins, C-Type; Leishmaniasis; Liposomes; Macrophages; Mannose; Mannose Receptor; Mannose-Binding Lectins; Mice; Particle Size; Rats; Rats, Wistar; Receptors, Cell Surface

2012
Protection against Leishmania major infection by oligomannose-coated liposomes.
    Bioorganic & medicinal chemistry, 2003, Apr-03, Volume: 11, Issue:7

    Topics: Adjuvants, Immunologic; Animals; Cholesterol; Excipients; Female; Immunoglobulin G; Leishmania major; Leishmaniasis; Liposomes; Lymph Nodes; Mannose; Mice; Mice, Inbred BALB C; Oligosaccharides; Parasite Egg Count; Phosphatidylethanolamines; Protozoan Vaccines

2003
Phospholipid microspheres: a novel delivery mode for targeting antileishmanial agent in experimental leishmaniasis.
    Journal of drug targeting, 2003, Volume: 11, Issue:2

    Topics: Animals; Antiparasitic Agents; Cholesterol; Cricetinae; Dose-Response Relationship, Drug; Indoles; Indolizines; Injections, Subcutaneous; Kidney; Lactic Acid; Leishmania donovani; Leishmaniasis; Liposomes; Liver; Mannose; Microspheres; Organophosphates; Phosphatidylethanolamines; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Spleen; Stereoisomerism; Structure-Activity Relationship

2003
Receptor-mediated entry of beta-glucuronidase into the parasitophorous vacuoles of macrophages infected with Leishmania mexicana amazonensis.
    The Journal of experimental medicine, 1983, May-01, Volume: 157, Issue:5

    Topics: Animals; Autoradiography; Cricetinae; Female; Glucuronidase; Kinetics; Lectins, C-Type; Leishmaniasis; Macrophages; Mannose; Mannose Receptor; Mannose-Binding Lectins; Mesocricetus; Mice; Mice, Inbred Strains; Receptors, Cell Surface; Serum Albumin; Vacuoles

1983
Synthesis of antimony complexes of yeast mannan and mannan derivatives and their effect on Leishmania-infected macrophages.
    The Biochemical journal, 1993, Jan-01, Volume: 289 ( Pt 1)

    Topics: Animals; Antimony; Antiprotozoal Agents; Carbohydrate Sequence; Cricetinae; Drug Carriers; Lectins, C-Type; Leishmania; Leishmaniasis; Macrophages; Mannans; Mannose; Mannose Receptor; Mannose-Binding Lectins; Meglumine; Meglumine Antimoniate; Mice; Molecular Sequence Data; Organometallic Compounds; Receptors, Cell Surface; Receptors, Immunologic; Saccharomyces cerevisiae

1993